Physician profile
Michael A Brown
NPI 1093719056
$7,922.47
in general payments reported to CMS, 2019-2025
35 companies · $757 in 2025
The $757 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $782 · 2020: $945 · 2021: $1,118 · 2022: $1,593 · 2023: $1,737 · 2024: $990 · 2025: $757.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,484.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,483.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $1,501.45 | 2019-2024 | Solia, Acticor 7 Vr-T Dx, Biomonitor |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $648.81 | 2019-2025 | Lifevest |
| Amarin Pharma, INC. | $565.53 | 2020-2021 | |
| Abbott Laboratories | $411.59 | 2019-2025 | Cardiomems, Gallant, Assurity |
| Novartis Pharmaceuticals Corporation | $407.35 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $390.44 | 2021-2024 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $360.24 | 2019-2025 | Camzyos, Eliquis |
| Amgen INC. | $349.25 | 2019-2025 | Repatha, Repatha |
| Atricure, INC. | $340.93 | 2021-2025 | Atriclip Laa Exclusion System, Epi-Sense Guided Coagulation System With Visitrax, Synergy Ablation System |
| Impulse Dynamics (USA) INC. | $340.32 | 2022-2023 | Optimizer |
| Heartflow, INC. | $319.97 | 2020-2025 | Ffrct |
| Philips North America LLC | $268.49 | 2024-2025 | (5044) Mcot, Mcot |
| Janssen Pharmaceuticals, INC | $260.59 | 2019-2023 | Xarelto |
| Bayer Healthcare Pharmaceuticals INC. | $259.82 | 2022-2025 | |
| Novo Nordisk INC | $253.60 | 2021-2023 | Rybelsus, Ozempic |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $226.17 | 2019-2023 | |
| Boston Scientific Corporation | $195.43 | 2019-2025 | Bodyguardian, Watchman Flx |
| Sanofi-Aventis U.S. LLC | $148.95 | 2021-2024 | |
| Astrazeneca Pharmaceuticals LP | $89.15 | 2022-2025 | Wainua |
| Merck Sharp & Dohme LLC | $77.29 | 2022-2024 | Verquvo |
| Kiniksa Pharmaceuticals International, Plc | $69.38 | 2024 | Arcalyst |
| Medtronic, INC. | $54.45 | 2025 | Affera Mapping System |
| Cathworks, INC. | $50.02 | 2019-2020 | |
| Lexicon Pharmaceuticals, INC. | $47.53 | 2023-2024 | Inpefa |
| Actelion Pharmaceuticals US, INC. | $42.67 | 2022 | |
| Esperion Therapeutics, INC. | $37.61 | 2024-2025 | Nexletol |
| Alnylam Pharmaceuticals INC. | $31.76 | 2024 | Amvuttra |
| Kestra Medical Technology Services, INC. | $30.35 | 2022 | |
| Medtronic Vascular, INC. | $25.55 | 2019-2020 | |
| Daiichi Sankyo INC. | $24.80 | 2023 | Injectafer |
| Regeneron Healthcare Solutions, INC. | $22.15 | 2024 | Evkeeza |
| Edwards Lifesciences Corporation | $20.60 | 2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Scpharmaceuticals INC. | $18.38 | 2025 | |
| Inspire Medical Systems, INC. | $17.72 | 2023 | Inspire |
| Abiomed | $14.13 | 2024 | Impella |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.